Septerna (NASDAQ:SEPN) Given New $61.00 Price Target at Wells Fargo & Company

Septerna (NASDAQ:SEPN) had its price target lifted by Wells Fargo & Company from $50.00 to $61.00 in a research report released on Wednesday,Benzinga reports. The firm currently has an overweight rating on the stock.

A number of other research firms also recently weighed in on SEPN. Raymond James Financial reissued a “strong-buy” rating and issued a $49.00 target price on shares of Septerna in a report on Tuesday, August 11th. Guggenheim boosted their price target on Septerna from $45.00 to $51.00 and gave the company a “buy” rating in a research note on Tuesday, August 11th. Weiss Ratings restated a “sell (d-)” rating on shares of Septerna in a research note on Thursday, October 15th. HC Wainwright upped their price target on shares of Septerna from $40.00 to $60.00 and gave the company a “buy” rating in a research report on Wednesday, August 12th. Finally, Stifel Nicolaus set a $49.00 price objective on shares of Septerna in a research note on Tuesday, August 11th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $53.67.

Septerna Trading Up 9.6%

Shares of SEPN stock opened at $47.88 on Wednesday. Septerna has a 12-month low of $17.55 and a 12-month high of $51.10. The stock has a market capitalization of $2.24 billion, a P/E ratio of -88.67 and a beta of 2.20. The firm’s 50 day moving average is $39.21 and its 200 day moving average is $32.38.

Septerna (NASDAQ:SEPN) last released its quarterly earnings results on Monday, August 10th. The company reported ($0.29) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.43) by $0.14. Septerna had a negative return on equity of 9.57% and a negative net margin of 24.51%. The firm had revenue of $26.75 million for the quarter, compared to the consensus estimate of $19.22 million. As a group, equities analysts predict that Septerna will post -1.41 earnings per share for the current year.

Insiders Place Their Bets

In other news, COO Elizabeth Bhatt sold 4,000 shares of the business’s stock in a transaction on Thursday, October 15th. The shares were sold at an average price of $37.41, for a total transaction of $149,640.00. Following the completion of the sale, the chief operating officer owned 174,209 shares of the company’s stock, valued at $6,517,158.69. The trade was a 2.24% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP Daniel Long sold 3,333 shares of the company’s stock in a transaction on Tuesday, September 1st. The stock was sold at an average price of $37.83, for a total value of $126,087.39. Following the completion of the sale, the senior vice president owned 96,412 shares of the company’s stock, valued at $3,647,265.96. This trade represents a 3.34% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 32,333 shares of company stock valued at $1,375,727. Insiders own 5.80% of the company’s stock.

Institutional Trading of Septerna

Several hedge funds have recently bought and sold shares of the stock. Covestor Ltd raised its stake in shares of Septerna by 19.0% in the third quarter. Covestor Ltd now owns 2,526 shares of the company’s stock worth $98,000 after buying an additional 403 shares during the period. Mirae Asset Global Investments Co. Ltd. purchased a new position in shares of Septerna during the 3rd quarter valued at about $93,000. Profund Advisors LLC purchased a new position in shares of Septerna during the 3rd quarter valued at about $1,497,000. VIRGINIA RETIREMENT SYSTEMS ET Al grew its stake in shares of Septerna by 24.8% during the 3rd quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 16,600 shares of the company’s stock valued at $650,000 after acquiring an additional 3,300 shares during the period. Finally, China Universal Asset Management Co. Ltd. grew its stake in shares of Septerna by 12.5% during the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 12,117 shares of the company’s stock valued at $474,000 after acquiring an additional 1,343 shares during the period.

Septerna Company Profile

Septerna, Inc is a clinical-stage biotechnology company focused on discovering and developing oral small-molecule medicines that target G protein-coupled receptors (GPCRs). GPCRs are a large class of cell-surface proteins involved in a wide range of biological processes and represent an important source of potential drug targets.

The company’s research is powered by its Native State platform, which is designed to study GPCRs in their natural biological configuration and support the discovery of selective small-molecule compounds.